Valutazione scintigrafica con metodica SPECT dell'effetto dei bifosfonati sul processo di osseointegrazione implantare.

Translated title of the contribution: Influence of biphosphonates on the integration process of endosseous implants evaluated using single photon emission computerized tomography (SPECT)

F. Bambini, C. A. De Stefano, L. Giannotti, L. Memè, M. Pellecchia

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Biphosphonates are a large class of drugs which inhibits the resorbing activity of osteoclasts. The aim of this study was to evaluate the influence of topical application of the biphosphonate alendronate on the integration process of endosseus implants placed in a partially edentulous patient. After incision and elevation of a mucoperiosteal flap and carrying out the osteotomy, 2 SLA implants 10 mm long and 3.5 mm wide were inserted in the area of # 4.5 and 4.6. Before placement of # 4.5, a paste made of grinded tablets of alendronate and Rifocin was applied in the osteotomy. Fifteen days after stage I, an evaluation of the osteoblastic peri-implant activity was carried out using single photon emission computerized tomography. Healing was within normal limits. Four months after stage I, the 2 implants were uncovered and considered clinically and radiographically integrated. The osteoblastic activity was judged similar bet-ween the 2 implants in terms of quality of biological response. Osseous scintigraphy and the achievement of implant osseointegration demonstrate the lack of toxicity of the topical application of the biphosphonate alendronate during the initial osseous healing. However, new experimental studies and clinical trials are necessary to confirm the results obtained.

Original languageItalian
Pages (from-to)331-338
Number of pages8
JournalMinerva Stomatologica
Volume52
Issue number6
Publication statusPublished - 2003

Fingerprint

Alendronate
Single-Photon Emission-Computed Tomography
Osteotomy
Osseointegration
Osteoclasts
Ointments
Radionuclide Imaging
Tablets
Clinical Trials
Pharmaceutical Preparations

Cite this

Bambini, F., De Stefano, C. A., Giannotti, L., Memè, L., & Pellecchia, M. (2003). Valutazione scintigrafica con metodica SPECT dell'effetto dei bifosfonati sul processo di osseointegrazione implantare. Minerva Stomatologica, 52(6), 331-338.

Valutazione scintigrafica con metodica SPECT dell'effetto dei bifosfonati sul processo di osseointegrazione implantare. / Bambini, F.; De Stefano, C. A.; Giannotti, L.; Memè, L.; Pellecchia, M.

In: Minerva Stomatologica, Vol. 52, No. 6, 2003, p. 331-338.

Research output: Contribution to journalArticle

Bambini, F, De Stefano, CA, Giannotti, L, Memè, L & Pellecchia, M 2003, 'Valutazione scintigrafica con metodica SPECT dell'effetto dei bifosfonati sul processo di osseointegrazione implantare.', Minerva Stomatologica, vol. 52, no. 6, pp. 331-338.
Bambini, F. ; De Stefano, C. A. ; Giannotti, L. ; Memè, L. ; Pellecchia, M. / Valutazione scintigrafica con metodica SPECT dell'effetto dei bifosfonati sul processo di osseointegrazione implantare. In: Minerva Stomatologica. 2003 ; Vol. 52, No. 6. pp. 331-338.
@article{3894a6ffd405490a8fbb024a57809c2b,
title = "Valutazione scintigrafica con metodica SPECT dell'effetto dei bifosfonati sul processo di osseointegrazione implantare.",
abstract = "Biphosphonates are a large class of drugs which inhibits the resorbing activity of osteoclasts. The aim of this study was to evaluate the influence of topical application of the biphosphonate alendronate on the integration process of endosseus implants placed in a partially edentulous patient. After incision and elevation of a mucoperiosteal flap and carrying out the osteotomy, 2 SLA implants 10 mm long and 3.5 mm wide were inserted in the area of # 4.5 and 4.6. Before placement of # 4.5, a paste made of grinded tablets of alendronate and Rifocin was applied in the osteotomy. Fifteen days after stage I, an evaluation of the osteoblastic peri-implant activity was carried out using single photon emission computerized tomography. Healing was within normal limits. Four months after stage I, the 2 implants were uncovered and considered clinically and radiographically integrated. The osteoblastic activity was judged similar bet-ween the 2 implants in terms of quality of biological response. Osseous scintigraphy and the achievement of implant osseointegration demonstrate the lack of toxicity of the topical application of the biphosphonate alendronate during the initial osseous healing. However, new experimental studies and clinical trials are necessary to confirm the results obtained.",
author = "F. Bambini and {De Stefano}, {C. A.} and L. Giannotti and L. Mem{\`e} and M. Pellecchia",
year = "2003",
language = "Italian",
volume = "52",
pages = "331--338",
journal = "Minerva Stomatologica",
issn = "0926-4970",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "6",

}

TY - JOUR

T1 - Valutazione scintigrafica con metodica SPECT dell'effetto dei bifosfonati sul processo di osseointegrazione implantare.

AU - Bambini, F.

AU - De Stefano, C. A.

AU - Giannotti, L.

AU - Memè, L.

AU - Pellecchia, M.

PY - 2003

Y1 - 2003

N2 - Biphosphonates are a large class of drugs which inhibits the resorbing activity of osteoclasts. The aim of this study was to evaluate the influence of topical application of the biphosphonate alendronate on the integration process of endosseus implants placed in a partially edentulous patient. After incision and elevation of a mucoperiosteal flap and carrying out the osteotomy, 2 SLA implants 10 mm long and 3.5 mm wide were inserted in the area of # 4.5 and 4.6. Before placement of # 4.5, a paste made of grinded tablets of alendronate and Rifocin was applied in the osteotomy. Fifteen days after stage I, an evaluation of the osteoblastic peri-implant activity was carried out using single photon emission computerized tomography. Healing was within normal limits. Four months after stage I, the 2 implants were uncovered and considered clinically and radiographically integrated. The osteoblastic activity was judged similar bet-ween the 2 implants in terms of quality of biological response. Osseous scintigraphy and the achievement of implant osseointegration demonstrate the lack of toxicity of the topical application of the biphosphonate alendronate during the initial osseous healing. However, new experimental studies and clinical trials are necessary to confirm the results obtained.

AB - Biphosphonates are a large class of drugs which inhibits the resorbing activity of osteoclasts. The aim of this study was to evaluate the influence of topical application of the biphosphonate alendronate on the integration process of endosseus implants placed in a partially edentulous patient. After incision and elevation of a mucoperiosteal flap and carrying out the osteotomy, 2 SLA implants 10 mm long and 3.5 mm wide were inserted in the area of # 4.5 and 4.6. Before placement of # 4.5, a paste made of grinded tablets of alendronate and Rifocin was applied in the osteotomy. Fifteen days after stage I, an evaluation of the osteoblastic peri-implant activity was carried out using single photon emission computerized tomography. Healing was within normal limits. Four months after stage I, the 2 implants were uncovered and considered clinically and radiographically integrated. The osteoblastic activity was judged similar bet-ween the 2 implants in terms of quality of biological response. Osseous scintigraphy and the achievement of implant osseointegration demonstrate the lack of toxicity of the topical application of the biphosphonate alendronate during the initial osseous healing. However, new experimental studies and clinical trials are necessary to confirm the results obtained.

UR - http://www.scopus.com/inward/record.url?scp=0642344663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0642344663&partnerID=8YFLogxK

M3 - Articolo

C2 - 12874537

AN - SCOPUS:0642344663

VL - 52

SP - 331

EP - 338

JO - Minerva Stomatologica

JF - Minerva Stomatologica

SN - 0926-4970

IS - 6

ER -